Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

Deciphering von Hippel-Lindau (VHL/Vhl)-associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations.

Shen HC, Adem A, Ylaya K, Wilson A, He M, Lorang D, Hewitt SM, Pechhold K, Harlan DM, Lubensky IA, Schmidt LS, Linehan WM, Libutti SK.

PLoS One. 2009;4(4):e4897. doi: 10.1371/journal.pone.0004897. Epub 2009 Apr 2.

PMID:
19340311
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Von Hippel-Lindau disease.

Sano T, Horiguchi H.

Microsc Res Tech. 2003 Feb 1;60(2):159-64. Review.

PMID:
12539169
[PubMed - indexed for MEDLINE]
3.

Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment.

Shuin T, Yamasaki I, Tamura K, Okuda H, Furihata M, Ashida S.

Jpn J Clin Oncol. 2006 Jun;36(6):337-43. Review.

PMID:
16818478
[PubMed - indexed for MEDLINE]
Free Article
4.

Role of the VHL (von Hippel-Lindau) gene in renal cancer: a multifunctional tumour suppressor.

Nyhan MJ, O'Sullivan GC, McKenna SL.

Biochem Soc Trans. 2008 Jun;36(Pt 3):472-8. doi: 10.1042/BST0360472. Review.

PMID:
18481984
[PubMed - indexed for MEDLINE]
5.

Von Hippel-Lindau disease and endocrine tumour susceptibility.

Woodward ER, Maher ER.

Endocr Relat Cancer. 2006 Jun;13(2):415-25. Review.

PMID:
16728571
[PubMed - indexed for MEDLINE]
Free Article
6.

[Von-Hippel-Lindau (VHL) protein function by initiation and progression of renal cancer].

Moch H.

Pathologe. 2008 Nov;29 Suppl 2:149-52. doi: 10.1007/s00292-008-1034-y. Review. German.

PMID:
18751708
[PubMed - indexed for MEDLINE]
7.

von Hippel-Lindau disease: recent advances and therapeutic perspectives.

Richard S; French VHL Study Group.

Expert Rev Anticancer Ther. 2003 Apr;3(2):215-33. Review.

PMID:
12722881
[PubMed - indexed for MEDLINE]
8.

The von Hippel-Lindau tumor suppressor protein: roles in cancer and oxygen sensing.

Kaelin WG.

Cold Spring Harb Symp Quant Biol. 2005;70:159-66. Review.

PMID:
16869749
[PubMed - indexed for MEDLINE]
9.

The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma.

Kaelin WG Jr.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):680s-684s. Review.

PMID:
17255293
[PubMed - indexed for MEDLINE]
Free Article
10.

[Von Hippel-Lindau disease: recent advances in genetics and clinical management].

Richard S, Parker F, Aghakhani N, Allegre G, Portier F, David P, Marsot-Dupuch K.

J Neuroradiol. 2005 Jun;32(3):157-67. Review. French.

PMID:
16134297
[PubMed - indexed for MEDLINE]
11.

[Genetics and angiogenesis: the example of von Hippel-Lindau disease].

Richard S, Ladroue C, Gad S, Giraud S, Gardie B; Réseau national maladie de VHL et prédispositions héréditaires au cancer du rein de l'Institut national du cancer (INCa).

Bull Cancer. 2007 Jul;94 Spec No:S170-9. Review. French.

PMID:
17846002
[PubMed - indexed for MEDLINE]
12.

Von Hippel-Lindau disease (VHL): a need for a murine model with retinal hemangioblastoma.

Park S, Chan CC.

Histol Histopathol. 2012 Aug;27(8):975-84. Review.

PMID:
22763871
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Treatment of kidney cancer: insights provided by the VHL tumor-suppressor protein.

Kaelin WG Jr.

Cancer. 2009 May 15;115(10 Suppl):2262-72. doi: 10.1002/cncr.24232. Review.

PMID:
19402056
[PubMed - indexed for MEDLINE]
Free Article
14.

VHL and p53: tumor suppressors team up to prevent cancer.

Semenza GL.

Mol Cell. 2006 May 19;22(4):437-9. Review.

PMID:
16713574
[PubMed - indexed for MEDLINE]
Free Article
15.

Von hippel-lindau: a tumor suppressor links microtubules to ciliogenesis and cancer development.

Kuehn EW, Walz G, Benzing T.

Cancer Res. 2007 May 15;67(10):4537-40. Review.

PMID:
17510376
[PubMed - indexed for MEDLINE]
Free Article
16.

[Pancreatic tumor: unusual onset of Von-Hippel Lindau syndrome].

Garberini A, Caricato M, Valeri S, Alloni R, Ausania F, Rosignoli A, Greco S, Rabitti C, Coppola R.

Suppl Tumori. 2005 May-Jun;4(3):S56. Review. Italian.

PMID:
16437901
[PubMed - indexed for MEDLINE]
17.

Ubiquitin pathway in VHL cancer syndrome.

Ohh M.

Neoplasia. 2006 Aug;8(8):623-9. Review.

PMID:
16925945
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The von hippel-lindau tumor suppressor protein: an update.

Kaelin WG Jr.

Methods Enzymol. 2007;435:371-83. Review.

PMID:
17998064
[PubMed - indexed for MEDLINE]
19.

Von Hippel-Lindau (VHL) disease: an update on the clinico-pathologic and genetic aspects.

Shehata BM, Stockwell CA, Castellano-Sanchez AA, Setzer S, Schmotzer CL, Robinson H.

Adv Anat Pathol. 2008 May;15(3):165-71. doi: 10.1097/PAP.0b013e31816f852e. Review.

PMID:
18434768
[PubMed - indexed for MEDLINE]
20.

The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer.

Kaelin WG Jr.

Nat Rev Cancer. 2008 Nov;8(11):865-73. doi: 10.1038/nrc2502. Epub 2008 Oct 16. Review.

PMID:
18923434
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk